Through the partnership, Gilead aims to increase access to artificial intelligence and analytics for improved manufacturing, clinical trial recruitment and biomarker discovery.
“With AWS as our preferred cloud provider, our researchers can use AWS’s portfolio of services to gain the insights, agility, and security needed to deliver new medicines at speed, and treat the individual according to their unique needs, not just the disease,” Marc Berson, Gilead’s senior vice president and chief information officer, said in a news release.
Gilead has moved more than 50 percent of its data center footprint to Amazon over the past year, according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
